Cargando…
Inhibition of Abelson Tyrosine-Protein Kinase 2 Suppresses the Development of Alcohol-Associated Liver Disease by Decreasing PPARgamma Expression
BACKGROUND & AIMS: Alcohol-associated liver disease (ALD) represents a spectrum of alcohol use-related liver diseases. Outside of alcohol abstinence, there are currently no Food and Drug Administration–approved treatments for advanced ALD, necessitating a greater understanding of ALD pathogenesi...
Autores principales: | Malnassy, Greg, Keating, Claudia R., Gad, Shaimaa, Bridgeman, Bryan, Perera, Aldeb, Hou, Wei, Cotler, Scott J., Ding, Xianzhong, Choudhry, Mashkoor, Sun, Zhaoli, Koleske, Anthony J., Qiu, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10520367/ https://www.ncbi.nlm.nih.gov/pubmed/37460041 http://dx.doi.org/10.1016/j.jcmgh.2023.07.006 |
Ejemplares similares
-
Integrin subunit beta 8 contributes to lenvatinib resistance in HCC
por: Hou, Wei, et al.
Publicado: (2022) -
Abelson Phosphorylation of CLASP2 Modulates its Association With Microtubules and Actin
por: Engel, Ulrike, et al.
Publicado: (2014) -
PPARgamma Deficiency Counteracts Thymic Senescence
por: Ernszt, David, et al.
Publicado: (2017) -
Serum adiponectin as a biomarker for in vivo PPARgamma activation and PPARgamma agonist-induced efficacy on insulin sensitization/lipid lowering in rats
por: Yang, Baichun, et al.
Publicado: (2004) -
Dysregulated Dscam levels act through Abelson tyrosine kinase to enlarge presynaptic arbors
por: Sterne, Gabriella R, et al.
Publicado: (2015)